UMM Institutional Repository

STUDI PENGGUNAAN GOLONGAN CALCIUM CHANNEL BLOCKER (CCB) PADA PASIEN GAGAL GINJAL KRONIK Penelitian Dilakukan di RSUD Dr. Iskak Tulungagung

Athiyah, Widdadul (2019) STUDI PENGGUNAAN GOLONGAN CALCIUM CHANNEL BLOCKER (CCB) PADA PASIEN GAGAL GINJAL KRONIK Penelitian Dilakukan di RSUD Dr. Iskak Tulungagung. Bachelors Degree (S1) thesis, University of Muhammadiyah Malang.

[img]
Preview
Text
PENDAHULUAN .pdf

Download (5MB) | Preview
[img]
Preview
Text
BAB I .pdf

Download (895kB) | Preview
[img]
Preview
Text
BAB II.pdf

Download (9MB) | Preview
[img]
Preview
Text
BAB III.pdf

Download (732kB) | Preview
[img]
Preview
Text
BAB IV.pdf

Download (907kB) | Preview
[img] Text
BAB V.pdf
Restricted to Registered users only

Download (7MB)
[img] Text
BAB VI .pdf
Restricted to Registered users only

Download (5MB)
[img] Text
BAB VII.pdf
Restricted to Registered users only

Download (354kB)
[img] Text
LAMPIRAN.pdf
Restricted to Registered users only

Download (2MB)

Abstract

Background: Chronic kidney disease is defined as abnormalities in kidney structure and function, present for 3 month or longer. One of the most caused on chronic kidney disease is hypertension. Hypertension will occur injury in afferent arterioles in blood vessels and filtration decreases. Pharmacological therapy for chronic kidney disease with hypertension one of them with calcium channel blocker (CCB). CCB provides a renoprotective effect as well as vasodilatation in the glomerular arteriol. Objective: The aimed of study was to know the usage patterns of CCB in chronic kidney disease patiens in Dr. Iskak Public Hospital Tulungagung. Method: The study employed observational with descriptive and retrospective design in chronic kidney disease patiens in Dr. Iskak Public Hospital Tulungagung. Result and Conclusion: The usage pattern of single calcium channel blocker was in 24 patients (13%) and a combination was in 164 patients (87%). single calcium channel blocker therapy is widely used Amlodipin with a dose 1x10mg p.o was 15 patient (64%). The most commontly used CCB combination therapy were two kombination was 101 patient (54%) is Amlodipin (1x10mg) p.o and Furosemid (1x40mg) i.v.

Item Type: Thesis (Bachelors Degree (S1))
Student ID: 201410410311233
Thesis Advisors: University of Muhammadiyah Malang
Keywords: CCB, Chronic kidney disease, Hypertension
Subjects: R Medicine > RS Pharmacy and materia medica
Divisions: Faculty of Health Science > Department of Pharmacy (48201)
Depositing User: Nurhadin Nurhadin
Date Deposited: 09 Jul 2019 03:46
Last Modified: 09 Jul 2019 03:46
URI : http://eprints.umm.ac.id/id/eprint/46849

Actions (login required)

View Item View Item
UMM Official

© 2008 UMM Library. All Rights Reserved.
Jl. Raya Tlogomas No 246 Malang East Java Indonesia - Phone +62341464318 ext. 150, 151 - Fax +62341464101
E-Mail : infopus[at]umm.ac.id - Website : http://lib.umm.ac.id - Online Catalog : http://laser.umm.ac.id - Repository : http://eprints.umm.ac.id

Web Analytics

UMM Institutional Repository is powered by :
EPrints Logo